Your browser doesn't support javascript.
loading
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Vogel, Victor G; Costantino, Joseph P; Wickerham, D Lawrence; Cronin, Walter M; Cecchini, Reena S; Atkins, James N; Bevers, Therese B; Fehrenbacher, Louis; Pajon, Eduardo R; Wade, James L; Robidoux, André; Margolese, Richard G; James, Joan; Lippman, Scott M; Runowicz, Carolyn D; Ganz, Patricia A; Reis, Steven E; McCaskill-Stevens, Worta; Ford, Leslie G; Jordan, V Craig; Wolmark, Norman.
Affiliation
  • Vogel VG; Magee-Womens Hospital, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pa 15213-3221, USA. vvogel@magee.edu
JAMA ; 295(23): 2727-41, 2006 Jun 21.
Article in En | MEDLINE | ID: mdl-16754727
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Raloxifene Hydrochloride / Selective Estrogen Receptor Modulators Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: JAMA Year: 2006 Type: Article Affiliation country: United States
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Raloxifene Hydrochloride / Selective Estrogen Receptor Modulators Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: JAMA Year: 2006 Type: Article Affiliation country: United States